title: Nephrocalcinosis and its relationship to treatment of hereditary rickets.
abstract: Renal ultrasonography was performed on 23 patients with X-linked hypophosphatemic rickets (XLH) and 11 patients with autosomal recessive vitamin D-dependent rickets (ARVDD). A pattern of increased echogenicity of the renal pyramids (ERP) was identified in 11/23 patients with XLH and 3/11 patients with ARVDD; this ultrasonographic finding has previously been associated with medullary nephrocalcinosis. Patients with XLH and ERP had significantly higher mean serum calcium and phosphate concentrations, more frequent episodes of hypercalcemia, and higher doses of oral vitamin D and phosphate during the first 3 years of therapy. Episodes of hypercalcemia were more frequent when patients received higher doses of vitamin D2 (greater than 4000 IU/kg/day) or 1,25-dihydroxycholecalciferol (greater than 40 ng/kg/day). Episodes of hypercalciuria were significantly increased at doses of greater than 20 ng/kg/day 1,25-dihydroxycholecalciferol. In patients with ARVDD, ERP was also correlated with vitamin D dose and frequency of hypercalcemia episodes. ERP was not associated with an elevation of serum creatinine or loss of urinary concentrating ability in either patient group.
authors.affiliation: Division of Nephrology, McGill University-Montreal Children's Hospital Research Institute, Quebec.
authors.forename: P R
authors.initials: PR
authors.lastname: Goodyer
authors.forename: J B
authors.initials: JB
authors.lastname: Kronick
authors.forename: S
authors.initials: S
authors.lastname: Jequier
authors.forename: T M
authors.initials: TM
authors.lastname: Reade
authors.forename: C R
authors.initials: CR
authors.lastname: Scriver
mesh_terms: D000293:Adolescent; D000328:Adult; D002118:Calcium / Q000097:blood / Q000652:urine; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D006934:Hypercalcemia / Q000150:complications; D007015:Hypophosphatemia, Familial / Q000150:complications / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009397:Nephrocalcinosis / Q000175:diagnosis / Q000209:etiology*; D010710:Phosphates / Q000627:therapeutic use; D012189:Retrospective Studies; D012279:Rickets / Q000150:complications / Q000188:drug therapy*; D014463:Ultrasonography; D014807:Vitamin D / Q000627:therapeutic use
chemical_list: D010710:Phosphates; D014807:Vitamin D; D002118:Calcium